bpc-157 / tb4 blend 5mg/5mg BPC157/TB500 BLEND Peptide Vial 5mg/5mg – Thoroughbred Labs BPC-157 + TB4-Frag - Apeiron

Maintenance Phase Monitoring Once both compounds are established and the semaglutide dose is stable, monitoring intervals can extend to every four to eight weeks for clinical assessments and every eight to twelve weeks for blood work

BPC-157 is investigational, not FDA-approved, and banned by WADA

Rocca C, Boukhzar L, Granieri MC, Alsharif I, Mazza R, Lefranc B, et al

DSIP promotes the modulation of central regulatory processes, working as a systemic antioxidant and modulating GABA, glutamate, and other neuronal systems

However, unregulated melanotan products pose serious risks, including multiple case reports that describe melanomas a very dangerous skin cancer emerging from existing moles shortly after melanotan use